​"Scientific studies carried out both in the USA and in Europe, published in peer reviewed medical journals, have proved that adding ABUS to FFDM in screening asymptomatic women with dense breast tissue improves the detection of invasive breast cancer cases significantly.

​

Reading the large number of ABUS images can be both time consuming and often distracting. It can be compared to paging through six books (six acquisitions). QVIEW CAD provides a single image of each acquisition ("book") by seeing through all the pages and automatically highlighting the entire 3D breast in a single image, pointing out the lesion and its location accurately. This makes reading much shorter and more focused. The combination of QVCAD added to ABUS will revolutionize our way of screening asymptomatic women with dense breasts."

​

László Tabár, M.D., F.A.C.R., 

(Hon) Professor Emeritus of Radiology,

Uppsala University, Faculty of Medicine, Sweden

​​

​

​

"Asian randomized controlled studies, J-START and Chinese RCT, suggest that screening breast cancer with ultrasound is effective in Asian women. I think automated breast ultrasound combined with QVCAD can assist in detecting more invasive breast cancer than mammography in mass screening."

​

Woo Kyung Moon, M.D., Ph.D.,

Professor of Radiology and Director of Breast Imaging Center

Seoul National University Hospital, Korea

​

​​

​​

"The FDA approval of QVCAD for ABUS represents a major innovation in early detection of breast cancer. The QVCAD pivotal study demonstrated that the use of QVCAD reduced the readers' ABUS review time with no decrease in diagnostic accuracy."

​

Marc Inciardi M.D.,

Section Head, Breast Imaging,

University of Kansas Hospital Medical Center, Kansas City, KS

​

​

​​

"QVCAD is a leading edge innovative system for ABUS, which has been meticulously designed to maintain diagnostic accuracy with reduced reading time. I have been using QVCAD as an investigational tool in my practice for three years and find that it is essential for my routine ABUS reading."

​

Kiyoshi Namba M.D.,

Executive Advisor,

Hokuto Breast Center, Hokuto Hospital, Obihiro, Hokkaido, Japan

​

​

​

"From my experience with QVCAD, I believe it will be a much-needed aid in shortening the learning curves of new ABUS users as well as increasing their confidence in interpreting ABUS exams. These critical elements will encourage adoption of this very important adjunctive screening modality."

​

Susan Roux M.D.,

Medical Director,

Carol Hatton Breast Care Center, Monterey, CA

​

  

​​

"The majority of Asian women have dense breasts. Ultrasound has proven to be very effective in breast cancer screening in Asia. Our study demonstrates that QVCAD improves radiologist performance in both accuracy and interpretation time for the detection of breast cancer. We believe that it also increases radiologist's diagnostic confidence in routine screening."

​

Lingyun Bao, M.D.,

Director of Department of Ultrasound,

The First People's Hospital of Hangzhou, Hangzhou, China

​

​

​​

"QVCAD represents the very best in breast cancer screening ultrasound technology. I have been using QVCAD as an investigational tool for two years and experienced decreasing reading time as well as increasing diagnostic confidence. I feel QVCAD will become the new standard-of-care in breast ultrasound interpretation."

​

Ian Grady M.D.,

Principal,

North Valley Breast Clinic, Redding, CA

​

​

​​​

"In reviewing an ABUS screening exam, I can initially examine the entire case in a single glance with QVCAD. From my early experience with QVCAD, I find ultrasound CAD much more critical for screening than mammography CAD."

​

Ralph Smathers M.D.,

Director,

Mammography Specialists Group, Los Gatos, CA

​

​